Aprogen Medicines Inc. (KRX:007460)
South Korea · Delayed Price · Currency is KRW 737.00
-8.00 (-1.07%)
Last updated: Sep 9, 2025, 9:08 AM KST
Aprogen Medicines Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -55,503 | -58,079 | -55,619 | -98,657 | -93,920 | -46,490 | Upgrade |
Depreciation & Amortization | 24,805 | 24,305 | 29,071 | 28,392 | 25,262 | 4,308 | Upgrade |
Loss (Gain) From Sale of Assets | -92.03 | 201.14 | -30.3 | 457.39 | - | 3.45 | Upgrade |
Asset Writedown & Restructuring Costs | 801.87 | 801.87 | 2,271 | 9,162 | 223.61 | 241.5 | Upgrade |
Loss (Gain) From Sale of Investments | -3,910 | -303 | -341.93 | 2,744 | 1,228 | 1,825 | Upgrade |
Loss (Gain) on Equity Investments | 38,409 | - | - | 1,489 | 9,543 | 9,780 | Upgrade |
Stock-Based Compensation | 1,416 | 1,718 | 1,613 | 707.67 | 2,445 | - | Upgrade |
Provision & Write-off of Bad Debts | 2,717 | 1,573 | -8.5 | -5,001 | - | -74.85 | Upgrade |
Other Operating Activities | -67,850 | -18,663 | -19,249 | -35,587 | -17,926 | 51,030 | Upgrade |
Change in Accounts Receivable | 5,232 | -207.69 | 1,749 | 3,395 | 778.84 | 4,177 | Upgrade |
Change in Inventory | 5,676 | 1,270 | -5,024 | -17,526 | -8,367 | 41.12 | Upgrade |
Change in Accounts Payable | -11,330 | -4,369 | -3,491 | -1,852 | 3,378 | -28.79 | Upgrade |
Change in Unearned Revenue | - | - | - | - | - | -166.97 | Upgrade |
Change in Income Taxes | - | - | 217.8 | 935.78 | 770.88 | 378.18 | Upgrade |
Change in Other Net Operating Assets | 36,482 | 6,761 | -9,315 | -2,151 | -8,155 | -2,491 | Upgrade |
Operating Cash Flow | -23,148 | -44,992 | -58,156 | -113,491 | -84,740 | 22,534 | Upgrade |
Capital Expenditures | -15,308 | -12,671 | -25,514 | -19,610 | -34,392 | -2,576 | Upgrade |
Sale of Property, Plant & Equipment | 163.33 | 83.04 | 2,273 | 131.65 | 40.06 | 54.15 | Upgrade |
Cash Acquisitions | -5,080 | - | - | 39,940 | - | - | Upgrade |
Divestitures | 55,501 | - | - | 29,285 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -4,948 | -10,473 | -29,371 | -5,209 | -474.06 | -391.26 | Upgrade |
Investment in Securities | -77,381 | -9,446 | 965.68 | 27,268 | 18,390 | -19,407 | Upgrade |
Other Investing Activities | -19,211 | -7,998 | 8,193 | -1,690 | -924.3 | -61,133 | Upgrade |
Investing Cash Flow | -66,264 | -40,504 | -43,452 | 70,172 | -12,790 | -168,494 | Upgrade |
Short-Term Debt Issued | - | 11,050 | 14,610 | 96,500 | 134,190 | - | Upgrade |
Long-Term Debt Issued | - | 36,350 | 96,546 | - | 30,845 | 70,000 | Upgrade |
Total Debt Issued | 181,906 | 47,400 | 111,156 | 96,500 | 165,035 | 70,000 | Upgrade |
Short-Term Debt Repaid | - | -11,350 | -40,110 | -7,500 | -27,000 | - | Upgrade |
Long-Term Debt Repaid | - | -12,967 | -8,481 | -1,873 | -30,220 | -643.93 | Upgrade |
Total Debt Repaid | -53,330 | -24,317 | -48,591 | -9,373 | -57,220 | -643.93 | Upgrade |
Net Debt Issued (Repaid) | 128,576 | 23,083 | 62,565 | 87,127 | 107,815 | 69,356 | Upgrade |
Issuance of Common Stock | - | 0.76 | 5,515 | 30.97 | 2,583 | 132,876 | Upgrade |
Repurchase of Common Stock | -0.1 | -0.1 | - | -15,791 | - | - | Upgrade |
Other Financing Activities | 32,407 | 63,537 | 26,216 | -561.9 | -0 | -31,222 | Upgrade |
Financing Cash Flow | 160,983 | 86,621 | 94,296 | 70,804 | 110,398 | 171,010 | Upgrade |
Foreign Exchange Rate Adjustments | -109.64 | 352.04 | -72.93 | -309.07 | 4.05 | -105.81 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - | Upgrade |
Net Cash Flow | 71,462 | 1,477 | -7,385 | 27,176 | 12,872 | 24,944 | Upgrade |
Free Cash Flow | -38,456 | -57,662 | -83,669 | -133,101 | -119,132 | 19,957 | Upgrade |
Free Cash Flow Margin | -30.20% | -38.41% | -55.57% | -169.88% | -453.05% | 15.70% | Upgrade |
Free Cash Flow Per Share | -137.39 | -223.17 | -354.27 | -657.66 | -687.14 | 352.97 | Upgrade |
Cash Interest Paid | 1,111 | 630.72 | 42.76 | 10,992 | 11,339 | 875.83 | Upgrade |
Cash Income Tax Paid | 1,923 | 220.01 | -2,128 | 3,291 | 398.92 | 294.64 | Upgrade |
Levered Free Cash Flow | -43,809 | -43,846 | -21,656 | -145,213 | 26,095 | -48,660 | Upgrade |
Unlevered Free Cash Flow | -42,228 | -43,216 | -21,261 | -139,022 | 39,697 | -45,391 | Upgrade |
Change in Working Capital | 36,060 | 3,454 | -15,862 | -17,199 | -11,594 | 1,909 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.